Seroprevalence study prior and post vaccination in cancer patients in principality of Andorra (COVONCO study)

ConclusionThe seroprevalence of antibodies against SARS-COV-2 in oncologic patients in Andorra was higher among females and patients who received hormonal therapy and surgery while patients with hematologic malignancies and biologic therapies showed lower seropositivity without finding differences in the type of tumour or anticancer treatment.

http://link.springer.com/10.1007/s00432-022-04141-8

Source: Journal of Cancer Research and Clinical Oncology - July 9, 2022 Category: Cancer & Oncology Source Type: research